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Edited by Gerrit van MeerAbstract The clathrin, COPI and COPII scaﬀolds are para-
digm vesicle coats in membrane traﬃcking. Recent advances in
our understanding of the caveolar coat have generated a new par-
adigm. It represents those membrane coats, where a considerable
part of the protein component is lipid modiﬁed, and integrated
into the cytosolic leaﬂet of the vesicle membrane by a hairpin-
like hydrophobic structure. Such coat proteins are permanently
associated with membranes, and form oligomers early after syn-
thesis. These oligomers assemble into a coat that has high aﬃn-
ity for particular lipids, creating lipid microdomains within the
membrane. The combined protein–lipid structure should be con-
sidered as the scaﬀold that entraps ligands, either through aﬃn-
ity with the protein or with the lipid component, and that has the
ability to shape membranes. Besides scaﬀolds assembled by cave-
olins, scaﬀolds assembled by reticulons and PHB domain-con-
taining proteins such as the reggie/ﬂotillin proteins ﬁt this
paradigm.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The past 30 years have seen a tremendous increase in our
understanding of basic membrane traﬃcking principles and
how these are regulated, and this is summarized and exten-
sively discussed in many reviews [1–5]. The prime paradigm
in our molecular understanding of membrane traﬃcking is
the ‘vesicle coat’. Vesicle coats concentrate ligands in budding
structures at donor membranes, generate membrane curvature,
aid in pinching oﬀ vesicles, and recruit speciﬁc SNAREs for
correct targeting to downstream ‘target membranes’. The clas-
sical vesicle coats (COPI, COPII, Clathrin) disassemble into
cytosolic subunits and dissociate from the vesicle once these
processes have taken place. What is left is a ‘naked vesicle’ that
contains sorted cargo destined for a downstream compart-
ment, the correct SNAREs that ensure the vesicle will indeed
fuse with membranes of the right destination compartment,
and a whole set of regulatory molecules, orchestrated by a spe-
ciﬁc RabGTPase. Upon fusion, soluble cargo is released into
the lumen of that compartment, and the membrane lipids
and trans-membrane proteins that were present in and made
up the vesicle membrane diﬀuse into the target membrane.*Corresponding author. Fax: +41 44 633 10 51.
E-mail address: pelkmans@imsb.biol.ethz.ch (L. Pelkmans).
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doi:10.1016/j.febslet.2006.08.077Multiple layers of complexity exist to control the basic prin-
ciple outlined above. The many individual molecular events
must be correctly timed and coordinated, rates and kinetics
of vesicle traﬃcking modulated, and downstream targeting
controlled. In addition, various physiological processes im-
pinge on these machineries at multiple levels to modulate
membrane-dependent signal transduction and to adapt synthe-
sis and membrane traﬃcking of particular cargo to the physi-
ological needs of the cell. Membrane traﬃcking is therefore
involved in both processing incoming signals, and in translat-
ing them into the correct physiological output.
More recent concepts in membrane biology have however
not yet been fully integrated into our general basic understand-
ing of membrane traﬃcking. These concepts emerge from the
discovery that lipids organize laterally within the lipid bilayer
to form, transiently or more stably, microdomains in which
certain lipid species are concentrated while others are depleted
[6,7]. The lipids themselves are believed to generate part of the
driving force behind lipid microdomain formation, since cer-
tain lipid species tend to be less miscible with other lipid spe-
cies within the bilayer. In addition, certain protein anchors
(e.g. GPI) or certain protein trans-membrane domains, might
favour a particular lipid microenvironment over another, lead-
ing to preferential partitioning into one or another microdo-
main. The concept of the so-called ‘lipid rafts’, membrane
microdomains especially enriched in glycosphingolipids and
cholesterol, is under extensive scientiﬁc scrutiny and debate
[8,9]. While no consensus has yet been reached on whether
lipid raft formation in mammalian cells can be lipid-driven
(it certainly can be in model membranes), it is clear that this
process can be protein-driven. Such polarized views are likely
to be inappropriate for cellular membranes, where microdo-
main formation must be a complex interplay of lipid–lipid,
lipid–protein, and protein–protein interactions. The proteins
involved are either multivalent cytosolic or extracellular pro-
teins that bind headgroups of speciﬁc lipids, or membrane-
integrated proteins with aﬃnity for particular lipid species that
form multimeric scaﬀolds. In this review, we will consider par-
ticular members of this latter group as a new paradigm of
membrane-shaping and -organizing proteins that operate
according to new, poorly understood principles.2. Biosynthesis and assembly of membrane-integrated coats: the
caveolar coat
The biosynthesis of scaﬀolds built from membrane-inte-
grated proteins starts in the endoplasmic reticulum (ER),blished by Elsevier B.V. All rights reserved.
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Fig. 1. Hypothetical model of coat assembly. (A) After co-translational insertion into the ER membrane, six or seven caveolin monomers form SDS-
resistant oligomers. (B) To prevent unwanted polymer assembly at this stage, oligomers are phosphorylated by an unknown kinase at serine80 (S80).
(C) Phosphorylated oligomers are transported to the Golgi complex where they are dephosphorylated by an unknown phosphatase. This triggers
polymerization and increased cholesterol aﬃnity. (D) Cooperative polymer assembly and high-aﬃnity binding to cholesterol leads to formation of a
caveolar coat, leading to (E) membrane curvature and budding of caveolar vesicles.
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con (Fig. 1A, B). Caveolin (Cav1, Cav2, and Cav3) synthesis
occurs at the ER membrane, where single molecules are co-
translationally integrated into the bilayer [10,11]. They do
not span the membrane, but form a hairpin loop within the bi-
layer, causing both the N- and the C-terminus of the protein to
be cytosolic. Caveolins form SDS-resistant oligomers (hexa- or
heptamers) soon after synthesis and still in the ER, probably
by coiled–coil interactions of cytosolic N-terminal domains
[10,12]. These oligomers leave the ER and are transported by
the secretory pathway to the Golgi complex [13] (Fig. 1C). If
onward traﬃc is prevented and caveolin accumulates in the
ER, the protein is increasingly found on lipid droplets [14–16].
Somewhere before caveolin oligomers reach the plasma
membrane but after they have left the ER, they are assembled
into a polymeric caveolar coat (Fig. 1). Assembly, which in-
volves a ﬁxed number (between 100 and 200) of Cav1 mole-
cules [17], shields a particular antigenic domain of the
protein, while it creates new antigenic domains [18]. This al-
lows the use of certain antibodies to distinguish between unas-
sembled and assembled caveolar coats. Apparently, newly
synthesized caveolin on the ER, caveolin on lipid droplets
and on part of the ER-Golgi intermediate compartment (ER-
GIC) or the perinuclear Golgi complex is recognized by one
type of antibodies, while caveolin on more peripheral Golgi-
derived membranes, on intracellular caveolar vesicles, caveo-
somes and endosomes, and on caveolae connected to the sur-
face is recognized by another type of antibodies [19].
Antigenic properties of newly synthesized Cav1 also reappearFig. 2. Putative membrane topologies of membrane-integrated coat subunits.
Reggie-1 (C) are depicted. They have an overall similar appearance, conta
domain, and have several phosphorylation sites on both sites of the hairpinwhen pre-assembled caveolar coats are disassembled on the
cell surface by active cholesterol extraction [18], indicating that
cholesterol has a structural/stabilizing role in coat assembly. In
addition, Cav1 organized into a caveolar coat appears to have
higher aﬃnity for cholesterol than oligomeric or monomeric
caveolin [20], suggesting a cooperative model of coat assembly
involving proteins and lipids.
It can be assumed that other structural proteins participate in
forming caveolar coats, but these are currently not known. Also
structural insights are completely lacking. Early scanning elec-
tron microscopy images gave the impression of spiral-like coats
on the cytosolic surface of caveolae [21], but there is currently
no evidence that this is indeed the deﬁning appearance of a
caveolar coat. The protein composition of these spiral-like
assemblies has not been determined, nor do we know any phys-
ical characteristics like ﬂexibility and tendency to self-assemble.
Unfortunately, the limited information has not yet provided
any intuitive models, like that in the case of clathrin coats.3. Common properties of caveolins, reggie/ﬂotillin proteins and
reticulons
A number of membrane-integrated proteins have been de-
scribed that share topological principles of caveolins (Fig. 2).
One class carries an evolutionarily conserved protein domain
called the prohibitin homology (PHB) domain, of which the
reggie/ﬂotillin proteins are well-known members [22,23]. The
PHB domain could have a hairpin-like topology, similar toMembrane topologies of Caveolin-1 (A), Reticulon 4c/NogoC (B) and
in at least one membrane-integrated, but not -spanning, hairpin-loop
loop near the lipid bilayer.
M. Bauer, L. Pelkmans / FEBS Letters 580 (2006) 5559–5564 5561the membrane domain of caveolins. The reticulons, in particu-
lar Rtn4c/NogoC and DP1, have two hydrophobic segments
that adopt this unusual hairpin-like topology [11]. There are
additional shared properties between these protein families.
They all partition in detergent-resistant membranes, they form
oligomers [22] (Rtn3 oligomerizes via its cytosolic N-terminal
domain like caveolins [24]), and they contain several putative
phosphorylation sites. Furthermore, caveolins and reticulons
are found on membranes with high positive curvature (caveo-
lae and peripheral ER tubules, respectively). Most likely this
curvature is induced by a local concentration of several hairpin
loops inserted into the cytosolic leaﬂet, which creates a larger
surface on the cytosolic than on the luminal side of the mem-
brane. In agreement with this, overexpression of caveolins cre-
ates more caveolae-like structures, while overexpression of
reticulons creates more ER tubules. Membrane insertion has
not been studied to this extent for PHB domains, and it is
therefore not known to which extent reggie/ﬂotillin proteins
create positive curvature on membranes. That they are present
on a particular type of endocytic vesicles may suggest that they
participate in shaping those membrane carriers [25].
Caveolins are involved in generating spherical shapes and
their grape-like assemblies, but also in forming tubules (e.g.
T-tubules in muscle cells by Cav3 [26]), while reticulons have
until now only been reported to be involved in generating
tubules of the peripheral ER [11]. Perhaps a particular stoichio-
metry and ordering of caveolar coat subunits allows inducing
curvature in one or in two dimensions, while reticulon com-
plexes can only induce curvature in one dimension. Structural
information of these polymers is required to address these
questions. The types of shapes that reggie/ﬂotillin proteins
can form are not known.4. Cyclic, regulated coat assembly and disassembly
If a cyclic assembly and disassembly reaction exists for this
type of coats, it must be principally diﬀerent from classical
coats that are built from cytosolic subunits. For reticulons
and reggie/ﬂotillin proteins information on cyclic assembly
and disassembly is currently very limited. For caveolar coats,
and in particular Cav1, there is evidence for such cycling
(Fig. 3). An important diﬀerence with classical coats is that a
cycle of Cav1 polymer assembly and disassembly is not neces-
sarily connected to a single membrane traﬃcking step between
two compartments. Pre-existing caveolar vesicles can dock on,
fuse with and leave from target membranes in a kiss-and-run
manner without fully disassembling their coat [27]. When spe-
ciﬁc ligands in these vesicles are either captured or released
during the kiss-and-run cycle, for instance upon receiving a
speciﬁc cue in the respective compartment, directional trans-
port and sorting can still be achieved.
Nevertheless, there is some evidence that suggests that the
caveolar coat may undergo triggered assembly and disassem-
bly [18,28] during biosynthesis of the caveolar coat, and when
caveolin is targeted to lipid droplets. In addition, as mentioned
before, some experiments suggest that caveolin polymers have
higher aﬃnity for cholesterol than caveolin monomers or smal-
ler oligomers [20]. Combined, this limited evidence suggests an
intriguing, although highly speculative model of coat cycling,
which is possibly linked to cholesterol sensing and/or trans-
port. The model does not incorporate the possibility that cave-olins can also be cytosolic, based on one report that a
dominant-negative mutant of dynamin, which is involved in
vesicular transport, may perturb this cycle [20]. However,
other models that take non-vesicular modes of caveolin trans-
port into the equation may certainly be valid, and extensive
experimentation is required to test other models.
A phospho-mimetic mutant of Cav1 at serine80 (S80E) is
not able to reach the cell surface [29], does not partition into
detergent-resistant membranes (DRMs, a crude method to
study potential partitioning into lipid rafts), and has lower
aﬃnity for cholesterol than wildtype Cav1 [30]. A phospho-
deletion mutant of serine80 (S80A) however has a high aﬃn-
ity for cholesterol, comparable to wildtype Cav1. This
suggests the existence of a phosphatase that dephosphorylates
Cav1 at serine80 to allow coat assembly, leading to an in-
creased binding of cholesterol, and partitioning into DRMs.
Full coats are however not formed in the ER, but somewhere
in the ERGIC or Golgi complex [10,14,33], indicating that
S80 is immediately phosphorylated on the ER membrane
upon synthesis of Cav1. At the Golgi complex, a phosphatase
may be encountered, which could bind to and/or is activated
by cholesterol or sphingolipids, which dephosphorylates S80
and thereby initiates cooperative coat assembly. One may
speculate that the serine/threonine phosphatase PP2A is in-
volved, as it can form a complex with oxysterol-binding
protein (OSBP) and cholesterol [34], and with a Golgi com-
plex-localized regulatory subunit (B56gamma) [35]. In addi-
tion, PP2A has been implicated previously in membrane
traﬃcking from the Golgi complex [36] and in Golgi complex
fragmentation [37]. Again, extensive experimentation will be
required to test this hypothesis.
The reverse of the above (i.e. coat disassembly, by depoly-
merization of cav1 polymers into smaller oligomers) may hap-
pen when polymerized caveolar coats encounter an active
kinase that phosphorylates Cav1 at S80. This could be medi-
ated by the same kinase that phosphorylates newly synthesized
Cav1 on the ER membrane, and might regulate caveolar coat
disassembly when caveolar vesicles are targeted to the ER or to
ER-derived lipid droplets [28]. Because polymerized Cav1 has
a higher aﬃnity for cholesterol than Cav1 as monomers or
small oligomers [20], the speculative model described above
provides one possible mechanism by which caveolar vesicles
could mediate directional cholesterol traﬃcking to lipid drop-
lets. A polymerized coat sequesters cholesterol to at least a 1:1
molar ratio with Cav1 molecules (100–200 per caveolar vesi-
cle), but probably more because the caveolar coat forms a lipid
raft microenvironment in which more cholesterol molecules,
together with sphingolipids will partition. When this coat dis-
assembles and Cav1’s aﬃnity for cholesterol reduces, at least
part of the cholesterol molecules will be released into the sur-
rounding lipid environment. On the surface of lipid droplets,
this may be facilitated by cholesterol esteriﬁcation, as choleste-
ryl esters do not bind to Cav1, and partition into the neutral
lipid interior of lipid droplets. In addition, it may be that the
lipid raft microenvironment is lost, leading to even additional
release of cholesterol molecules. And, because the single leaﬂet
that surrounds lipid droplets are in regulated continuity with
the outer leaﬂet of the ER membrane, the disassembled cave-
olar coat subunits can be recycled via the biosynthetic route
for a new round of transport. Since the S80A mutant of
Cav1 does not cause newly synthesized Cav1 to accumulate in
the ER (our unpublished observations), S80 phosphorylation
Fig. 3. Suggested cycle of caveolar coat assembly and disassembly. The speculative model presented in this ﬁgure relies on three key steps. (A) The
ﬁrst step occurs directly after synthesis of new Cav1 molecules, or after the completion of one cycle. An unknown serine/threonine kinase
phosphorylates Cav1 at S80, which prevents it from forming larger polymers. For newly synthesized Cav1 this is suggested to occur on the ER
membrane. After the completion of one cycle it may occur on the surface of a lipid droplet, which might be regarded as an extension of the ER, or on
the ER itself. Alternatively, it may also occur at other subcellular locations, which are not included in this model. (B) Presumably upon arrival at the
Golgi complex, Cav1 is dephosphorylated at S80 by an unknown serine/threonine phosphatase, which now allows Cav1 polymerization, which
results in the sequestration of cholesterol into the polymeric complex, and ﬁnishes with the formation of a caveolar vesicle. (C) At some point during
the traﬃcking of caveolar vesicles (which may have come from the cell surface, intracellular endosomal compartments, or even directly from the
Golgi complex) they are targeted to a compartment where they encounter an unknown serine/threonine kinase that phosphorylates Cav1 at S80. In
this model, it is suggested that this occurs on lipid droplets and/or the ER, but other locations are certainly also possible. This would result in
disassembly of the cav1 polymers into smaller oligomers, leading to a reduced aﬃnity for cholesterol and reduced lipid raft formation capacity. Lipids
might be released into the surrounding bilayer, or in the case of lipid droplets, deposited onto the single leaﬂet surface and droplet interior. The
kinase in (A) might well be the same as in (C), especially if these reactions occur on the same organelle, like the ER or ER-associated organelles. This
establishes a closed cycle, which supports cyclic lipid sequestration at the location where the caveolar coat is assembled, and lipid release where the
coat is disassembled.
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signal to initiate coat disassembly or to prevent unwanted
assembly, perhaps to guarantee that cholesterol is sequestered
and released at the right place. In adipocytes, where the surface
is literally covered with caveolae and Cav1 expression is very
high, vectorial transport of a large number of cholesterol mol-
ecules could be achieved in this way. However, it must be
stressed that the above model is highly speculative. It would
for instance imply that caveolar vesicles would be able to
hemi-fuse with lipid droplets, for which there is currently no
evidence at all. In addition, after depolymerization of the cave-
olar coat and release of cholesterol, the hemi-fused vesicle
must somehow be able to pinch oﬀ from the lipid dropletagain, or fuse completely with the ER membrane if lipid drop-
lets were in continuity with that organelle. All these specula-
tions remain to be tested.
Although it is likely that the subcellular locations and the
particular kinases and phosphatases in the above-described
model will be diﬀerent for reggie/ﬂotillin proteins and reticu-
lons, the principle itself might well be similar. Indeed, all pro-
teins have putative phosphorylation sites close to the
membrane, and the possibility to oligomerize, which suggests
a general phosphorylation-dependent regulation of coopera-
tive assembly and lipid binding. For reggie/ﬂotillins and retic-
ulons, it is however not known to which lipids they have high
aﬃnity, dependent on polymerization state.
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As is often the case with diseases caused by perturbations of
membrane traﬃcking systems, the symptoms are diﬃcult to
trace back to the underlying molecular machinery. The reason
is that the vesicles formed by membrane scaﬀolds sequester
and transport many signaling molecules, and in this way par-
ticipate in maintaining the spatial and temporal network of
signal processing in mammalian cells. A perturbation of one
type of scaﬀold does often not lead to a complete block of
a certain traﬃcking and/or signaling route, but to an altered
equilibrium of the traﬃcking and signaling networks in which
it participates. To be able to predict these changes requires a
systems approach to membrane traﬃcking in mammalian
cells, which ﬁrst careful steps are being taken only now
[31,32].
Nevertheless, some clinical symptoms suggest being explain-
able directly by the malfunctioning of membrane scaﬀolds, but
this is highly speculative. For caveolar coats, explainable clin-
ical symptoms may be those caused by mutations in Cav3
linked to muscular dystrophy. This may be manifested through
the improper generation and/or maintenance of T-tubules in
striated muscle cells. In addition, levels of Cav1 expression
have been linked to obesity, which might be explained by an
improper cholesterol and lipid transport to lipid droplets in
adipocytes [28]. For reggie/ﬂottilin proteins, links with protein
aggregate-induced neurodegenerative diseases such as Alzhei-
mer’s disease and prion diseases have been described [22].
Explanation is not straightforward, but may be caused by a
malfunctioning of reggie/ﬂottilin-dependent clustering of the
aggregate-forming membrane-associated proteins, according
to the hypothetical models presented in this review. This could
be occurring in neuronal cells, but also in immune cells (espe-
cially for prions) that transport aggregates of misfolded pro-
teins around the body. Indeed, reggie/ﬂottilin proteins are
highly abundant in both cell types [22]. Reticulons have been
implicated in neuronal regeneration and also in neurodegener-
ative diseases [38,39]. This might be explained by a recent ﬁnd-
ing that the ER expands very long peripheral tubules into
neurite outgrowths that seem to functionally resemble smooth
ER [40]. Considering that reticulons are important for ER tu-
bule formation, neuronal disorders might be explained
through inappropriate assembly of ER tubules in neuritis. This
is however highly speculative, since the role of peripheral ER
tubules in neuronal cell functioning is currently not under-
stood.6. Outlook
While the wealth of, sometimes contradictory, information
on caveolins asks for structural studies that can clarify remain-
ing uncertainties, the situation for reggie/ﬂotillin proteins and
reticulons is diﬀerent. Classical biochemical analysis is needed
to study scaﬀold assembly, oligomerization, polymerization,
phosphorylation/dephosphorylation and lipid binding.
According to the hypothetical framework provided here, rapid
progress will hopefully be booked. It will be very interesting to
see if these protein scaﬀolds indeed behave according to similar
principles. For a full structural understanding, comparable to
other membrane coats, we will require methods that can reveal
the structure of large protein complexes within a membrane atatomic resolution, and develop in vitro systems that can study
assembly and disassembly of these coats within the plane of
lipid bilayers. We predict that these coats are signiﬁcant deter-
minants of organelle shapes, and a better understanding of
their molecular assembly and disassembly mechanisms will
allow us to formulate models on how particular organelle
shapes are created.
Another important aspect is to integrate these scaﬀolds into
the emerging complex network of membrane traﬃcking. Do
they interact with classical membrane traﬃcking machinery
such as SNAREs, are they controlled by RabGTPases, and
how are they capable of ligand sequestration and release?
Some of the scaﬀolds (caveolins, reggie/ﬂotillins) appear to
constitute coats of emerging membrane traﬃcking routes that
are independent of classical coats. Perhaps several, currently
unknown membrane traﬃcking routes exist, based on the
number of proteins that can form this type of scaﬀolds. How
do these routes integrate with other routes, and how do they
together form a complex network in space and time. Perhaps,
the ‘classical’ coats determine only a modest fraction of all
existing membrane traﬃcking mechanisms and routes in mam-
malian cells. An integrated understanding of membrane traf-
ﬁcking will require a custom-tailed systems approach. In
part, this can build on emerging systems approaches in cellular
signaling, but will also require the development of new physi-
cal and chemical concepts, in order to describe reactions that,
on a small and local scale, take place in two dimensions (lipid
bilayers), but whose integrated action determines the three-
dimensional surface of complex organelles (e.g. tubules, rib-
bons, grapes, reticuli) with dynamic shapes and changing
locations.
Finally, it will be crucial to elucidate the underlying regula-
tory network of coat assembly and disassembly, and to link
this to cellular physiology. Which are the kinases and phos-
phatases involved, how are they regulated, and in which sig-
naling networks do these participate? Are the molecular
(dis)assembly mechanisms of these scaﬀolds linked to systems
that sense speciﬁc lipids, such as cholesterol? This may reveal
how particular cellular needs regulate and control the shaping
of organelles, and how particular organelle shapes can con-
tribute to the cellular response. Besides a better understand-
ing of the basic mechanisms of organelle assembly in an
‘average’ mammalian cell, such insights may also contribute
to understanding the process of ER expansion in maturing
B lymphocytes, ER-mediated phagocytosis in macrophages,
ER tubulation in developing neurons, tubulation of late
endosomes in maturing dendritic cells, the expansion of
grape-like caveolar assemblies and their lipid-stimulated
internalization to lipid droplets in diﬀerentiating adipocytes,
etc.
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